Docetaxel dose reductions below 75 mg/m ( 2 ) were more common in patients from Asia ( 47.0 % ) than other regions ( 13.4 % ) ; docetaxel dose escalations to 100 mg/m ( 2 ) were less frequent in Asia ( 2.4 % ) than other regions ( 18.7 % ) .